Sanofi (SNY) announced the immediate adoption of influenza strains selected by the Food and Drug Administration to advance the manufacturing ...
Sanofi stock is surging with a Golden Cross formation and promising Dupixent results. With FDA review and potential approval, investors are excited.
Heading into the 2025 season, the Louisville Bats will have a new logo that draws on the history of the franchise and the legacy of where they play - Louisville, Kentucky. The Bats are the Triple ...
Sanofi has begun 2013 on a positive note after announcing that it has 65 New Molecular Entity (NME) projects and vaccine candidates in clinical development. Of this 65, 17 are already in phase 3 ...
In groundbreaking clinical trials, Sanofi's experimental drug ataciguat has significantly slowed the advancement of aortic valve stenosis, a prevalent heart condition, researchers revealed. The new ...
Detailed trial results could help Sanofi and Teva Pharmaceuticals make a case that a drug they’ve been developing will be competitive with rival treatments from Merck & Co. and Roche. The data, ...
TEVA), and Sanofi today presented new, detailed results from the RELIEVE UCCD Phase 2b study of duvakitug (TEV’574/SAR447189), a human IgG1-λ2 monoclonal antibody targeting TL1A, for the ...
Meghan Markle faces a new crisis over the logo design of her new brand, As Ever, it has been revealed. The 43-year-old has been accused of copying Majorca town's coat of arms on the new logo for ...
It's fascinating how the new MSN logo combines elements from different eras. You'll spot the vibrant colour gradients reminiscent of the original. I've seen countless logo redesigns, but Microsoft's ...
Apple CEO Tim Cook has confirmed that Apple will launch a new product today, Wednesday, February 19. The most likely release is the much-anticipated iPhone SE 4, but there are a few other ...
Paris, February 19, 2025. Following completion of the required social and corporate procedures, Sanofi and CD&R announce today they have signed the share purchase agreement in relation to the sale ...